Answers are grounded in this paper and cite their sources.
With the rationale that exposure to particulate matter (PM) and its oxidative burden may induce oxidative stress and inflammation, leading to impaired lung function, we conducted a systematic review using the Scopus database. Studies involved COPD populations, either alone or together with individuals with other respiratory diseases, and healthy participants. Findings were classified according to whether they supported the hypothesis that higher PM exposure increases oxidative stress and inflammation or impairs lung function. Cumulative net support indices were calculated based on the balance between supportive and contrary associations. A total of 63 studies (164 exposure records) were included, with PM2.5 and PM10 being the most frequently assessed exposure metrics. Most studies evaluated short-term PM exposure using ambient monitoring data, while personal exposure measurements and long-term assessments were less common. Regarding systemic oxidative stress, the evidence of adverse health effects was higher for 8-isoprostane and MDA, with net support indices of 83.3% and 77.8%, respectively, and lower for 8-OHdG (41.7%). For FeNO (airway inflammation), an overall net support of 66.7% was calculated. In relation to systemic inflammation, net support indices were 88.9% for TNF-α, 83.3% for IL-8, 81.3% for CRP, and 11.1% for IL-6. Finally, the strongest evidence of adverse effects on lung function was observed for FVC (83.3%), followed by FEV1 (55.9%) and PEF (36.0%). As a conclusion, overall evidence supports adverse effects of PM exposure on systemic oxidative stress, airway and systemic inflammation, and lung function in patients with COPD.
No takes yet. Share an insight, caveat, or question.
Fernández-Olmo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: